Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2019 (pdf):
Abstract (in Norwegian)
Download in single page format - double page (broad) format

Publication overview

Current news and events

PNAS publication:Allows for new treatment of covid-19 patients

From left: Søren Pischke, Tom E. Mollnes and Jan C. Holter
From left: Søren Pischke, Tom E. Mollnes and Jan C. Holter

Researchers from Oslo University Hospital and Vestre Viken show that activation of the innate immune system contributes to breathing difficulties in covid-19 patients. In a study recently published in the prestigious journal "Proceedings of the National Academy of Science" they show that systemic and long-term activation of the complement system occurred in 39 Norwegian covid-19 patients who were hospitalized.

OUH scientists Søren Pischke and Jan Cato Holter are shared first authors, and Tom Erik Mollnes is last author. They have also written a populuar science article about the findings.

Industry development agreement for innovative eye syringe

Morten C. Moe (left) and Jan Teje Andersen
Morten C. Moe (left) and Jan Teje Andersen

The Department of Ophthalmology at Oslo University Hospital and the Laboratory of Adaptive Immunity and Homeostasis of both Oslo University Hospital and University of Oslo, have entered an industry development agreement with the Dutch medical device company SJJ Solutions. The collaboration has resulted in a prototype of a tailor-made syringe optimised for eye injections.

The UiO's Innovation Prize for 2020 awarded to Bjarne Bogen

Bjarne Bogen
Bjarne Bogen

A unanimous prize committee highlights Bogen’s contributions to medical vaccine research as critical to the field of medicine and research-based innovation at the University of Oslo. Bjarne Bogen is head of the Cellular and Molecular Immunology research group at the Department of Immunology, under the Division of Laboratory Medicine. He is a professor at the Institute of Clinical Medicine and previously headed the K.G. Jebsen Centre for Influenza Vaccine Research, which closed in 2019. The award was distributed on September 2nd during the University of Oslo’s Annual Celebration.

Units and subpages

View all subunitsHide all subunits